Completed PHASE2 INTERVENTIONAL NCT01214395

Nasal Tea Tree Oil for the Prevention of Infections in PD Patients

An Investigator Blinded Controlled Study of the Nasal Application of 5% Tea Tree Oil (TTO) for the Prevention of Catheter-associated Infections in Renal Dialysis Patients

Sponsor: PathWest Laboratory Medicine WA

Conditions End Stage Renal Failure on Dialysis

Interventions 5% tea tree oil nasal ointment

Updated 5 times since 2017 Last updated: Jun 22, 2012 Started: Jun 30, 2010 Primary completion: Nov 30, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on End Stage Renal Failure on Dialysis, this trial is completed. The trial is conducted by PathWest Laboratory Medicine WA and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PathWest Laboratory Medicine WA

Data source: PathWest Laboratory Medicine WA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Perth, Australia